As 2019 begins, Lora Shimp, co-director of JSI’s Immunization Center, provides her thoughts on how the global immunization community is envisioning the exciting decade ahead.
Recently, JSI, in partnership with Nexleaf Analytics, installed ColdTrace 5, a remote temperature monitoring (RTM) device, in 120 vaccine storage sites across Tanzania. RTM solutions monitor the temperature of vaccine cold chain equipment in real time, send SMS alerts to health workers when temperature excursions occur, and provide valuable data and analytics to improve the overall cold chain. Seeing the performance of the fridge in real time allows for better management of the cold chain equipment and vaccines.
In this episode, you will hear from JSI Immunization Expert, Robert Steinglass. He talks to JSI Program Manager, Adriana Alminana about the importance of vaccination for improved public health and the growing need to increase focus on strengthening routine immunization systems for sustainability and equity.
The Internet of Things is already taking off in many different areas: in healthcare with drones delivering medical supplies to remote areas; energy management systems for buildings that will automatically adjust the window blinds based on the temperature; or traffic conditions that update your Google maps and give you real-time driving directions. In Tanzania, we are using it to manage vaccines so that children can receive safe vaccinations and lead healthy lives.
Last year, it was estimated that 1,804 of the 3,194 women in Madagascar who suffered from cervical cancer died. The HPV vaccine is not only a cost-effective method to prevent the economic burden of cervical cancers; it also protects against other types of cancers and symptoms of HPV, such as pelvic inflammatory disease.
Rapid urbanization presents an urgent challenge for the world’s low- and middle-income countries. More than half of world’s population (3.9 billion) now lives in a city; by 2050, this number will skyrocket to 6.3 billion, with 90 percent of growth occurring in low- and middle-income countries. The first step to meeting the immunization needs of the urban poor is revealing the obstacles to vaccine access.
For Nigeria to improve its health outcomes, particularly to end vaccine-preventable child deaths, the highest level of commitment and accountability from Nigerian leaders is imperative.
We set out to better understand whether smaller vaccine vial sizes could affect immunization coverage, timely coverage, and other factors in 14 districts of Zambia’s Central and Luapula Provinces.
In Ethiopia, the Universal Immunization through Improving Family Health Services project is using quality improvement methods and tools to enable health workers to use data for decision making.
We, as partners working in the immunization supply chain, must adapt and be willing to question the status quo in order to bring about improvements, increase access to potent vaccines, and ultimately increase coverage rates.